- Klopfleisch R, Meyer A, Schlieben P, Bondzio A, Weise C, Lenze D, et al. Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes. BMC Vet Res. 2012;8:96 pubmed publisher..These pathways may contain hypothetical targets for a combination therapy with masitinib to further improve its therapeutic effect. ..
- Klopfleisch R, Kohn B, Gruber A. Mechanisms of tumour resistance against chemotherapeutic agents in veterinary oncology. Vet J. 2016;207:63-72 pubmed publisher..The known resistance mechanisms in animal tumours and the potential of these findings for improving treatment efficacy in veterinary oncology are also explored. ..
- Saran S, Tran D, Klebba Färber S, Morán Losada P, Wiehlmann L, Koch A, et al. THOC5, a member of the mRNA export complex, contributes to processing of a subset of wingless/integrated (Wnt) target mRNAs and integrity of the gut epithelial barrier. BMC Cell Biol. 2013;14:51 pubmed publisher..These data imply that THOC5 may be a useful tool for studying intestinal stem cells, for modifying the differentiation processes and for cancer therapy. ..
- Bulkowska M, Rybicka A, Senses K, Ulewicz K, Witt K, Szymańska J, et al. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours. BMC Cancer. 2017;17:728 pubmed publisher..However, validation of cfa-miR-144, cfa-miR-32 and cfa-miR-374a levels in blood samples did not follow changes observed in the non-metastatic and metastatic tumours. ..